Cpda-1
NDC Package 0942-6321-04
Package Information
Cpda-1 is a . Marketed by Fenwal, Inc., this product is identified by NDC 0942-6321 and is authorized under FDA application BN770420.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0942 - Fenwal, Inc.
- 0942-6321 - Cpda-1
- 0942-6321-04 - 35 mL in 1 BAG
- 0942-6321 - Cpda-1
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0942-6321-04 identifies a specific commercial package of 35 ml in 1 bag of Cpda-1, labeled by Fenwal, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Fenwal, Inc. on June 01, 2007. The current certification is valid through March 29, 2013.
How is this Fenwal, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00942632104. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.